Item 2. Properties
Item 2. PROPERTIES.
Our headquarters are located in Wilmington, Delaware, USA. Our research and development activities are conducted primarily in facilities located in Conshohocken, Pennsylvania, USA; London, United Kingdom; Montreal, Canada; New York, New York, USA; Los Altos, California, USA; and Rennes, France.
The following table sets forth information with respect to our principal leased properties:
Location Approximate Square Feet Principal Use Lease Expiration Date
Wilmington, Delaware 36,200 Corporate headquarters November 2022
Rennes, France 50,000 Office and research space October 2024
Conshohocken, Pennsylvania 30,300 Office and research space September 2026
New York, New York 19,400 Office and research space July 2030
Montreal, Quebec 11,918 Office and research space June 2026
Los Altos, California 4,900 Office and research space November 2027
We are also a party to leases for several smaller research and/or office spaces, including in Brussels, Belgium; Espoo, Finland; Indianapolis, Indiana, USA; London, United Kingdom; Paris, France; and Hicksville, New York, USA. In addition, we own a building in Washington, District of Columbia, USA, that houses administrative office space.
We believe that the facilities described above are suitable and adequate for our present purposes and our needs in the near future.
Item 3. LEGAL PROCEEDINGS.
See Note 11, “ Litigation and Legal Proceedings ,” to the Notes to Consolidated Financial Statements included below in Part II, Item 8 of this Form 10-K for a description of our material legal proceedings, which is incorporated herein by reference.
Item 4. MINE SAFETY DISCLOSURES.
Not applicable.
26
Table of Contents
PART II
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.